Your browser doesn't support javascript.
loading
Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer.
Vollenbrock, S E; Voncken, F E M; van Dieren, J M; Lambregts, D M J; Maas, M; Meijer, G J; Goense, L; Mook, S; Hartemink, K J; Snaebjornsson, P; Ter Beek, L C; Verheij, M; Aleman, B M P; Beets-Tan, R G H; Bartels-Rutten, A.
Affiliation
  • Vollenbrock SE; Department of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Voncken FEM; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
  • van Dieren JM; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Lambregts DMJ; Department of Gastrointestinal Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Maas M; Department of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Meijer GJ; Department of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Goense L; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Mook S; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Hartemink KJ; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Snaebjornsson P; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Ter Beek LC; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Verheij M; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Aleman BMP; Department of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Beets-Tan RGH; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Bartels-Rutten A; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Br J Surg ; 106(5): 596-605, 2019 04.
Article in En | MEDLINE | ID: mdl-30802305
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Adenocarcinoma / Neoplasm, Residual / Neoadjuvant Therapy / Diffusion Magnetic Resonance Imaging / Chemoradiotherapy, Adjuvant Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Surg Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Adenocarcinoma / Neoplasm, Residual / Neoadjuvant Therapy / Diffusion Magnetic Resonance Imaging / Chemoradiotherapy, Adjuvant Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Surg Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom